TFF Pharmaceuticals, Inc. Common Stock
TFFP
TFFP was delisted on the 12th of December, 2024.
63 hedge funds and large institutions have $96.1M invested in TFF Pharmaceuticals, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 8 closing their positions.
200% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 8
73% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 11
56% more call options, than puts
Call options by funds: $3.3M | Put options by funds: $2.11M
34% more funds holding
Funds holding: 47 → 63 (+16)
4% more capital invested
Capital invested by funds: $92.8M → $96.1M (+$3.26M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
+$8.35M |
| 2 |
ACM
Altium Capital Management
New York
|
+$4.39M |
| 3 |
CA
Corriente Advisors
Fort Worth,
Texas
|
+$3.51M |
| 4 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
+$3.42M |
| 5 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$3.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$22.5M |
| 2 |
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Austin,
Texas
|
-$3.23M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$2.36M |
| 4 |
6CM
683 Capital Management
New York
|
-$2.03M |
| 5 |
SC
Sepio Capital
Salt Lake City,
Utah
|
-$1.5M |
TFFP Hedge Fund Activity: Q1 2021 in Review
63 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in TFF Pharmaceuticals, Inc. Common Stock (TFFP) for Q1 2021, worth a combined $96.1M — up 3.5% from $92.8M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new TFFP positions and 8 closed out — a net gain of 16 holders — while 19 added to existing stakes and 11 trimmed.
The largest buyer was DRW Securities, opening a new position worth an estimated $8.35M. The largest seller was Nantahala Capital Management, cutting an estimated $22.5M.
- 63 institutional investors held TFF Pharmaceuticals, Inc. Common Stock (TFFP) as of Q1 2021, up from 47 in Q4 2020.
- Funds reported $96.1M of TFF Pharmaceuticals, Inc. Common Stock stock for Q1 2021, up 3.5% quarter-over-quarter.
- 24 funds opened new TFF Pharmaceuticals, Inc. Common Stock positions in Q1 2021 and 8 closed out, a net change of +16 holders.
- The largest TFF Pharmaceuticals, Inc. Common Stock buyer in Q1 2021 was DRW Securities, an estimated $8.35M added.
- The largest TFF Pharmaceuticals, Inc. Common Stock seller in Q1 2021 was Nantahala Capital Management, an estimated $22.5M sold.
Based on aggregated 13F filings for Q1 2021.